Date Informed Consent Obtained (Date informed consent obtained)
CL Item
Does The Participant Have A Diagnosis Of Untreated Aggressive B-cell Lymphoma, Including Diffuse Large B Cell/immunoblastic, Burkitt's, Or Hodgkin's Lymphoma (Does the participant have a diagnosis of untreated aggressive B-cell lymphoma, including diffuse large B cell/immunoblastic, Burkitt's, or Hodgkin's lymphoma)
CL Item
Does The Participant Have Diagnostic Material From Fresh Frozen Tissue Or Formalin-fixed Paraffin Embedded Tissue Available (Does the participant have diagnostic material from fresh frozen tissue or formalin-fixed paraffin embedded tissue available)
CL Item
Does The Participant Have Serologic Documentation Of Hiv Infection At Any Time Prior To Study Entry, As Evidenced By Any Federally Approved Hiv Test (Does the participant have serologic documentation of HIV infection at any time prior to study entry, as evidenced by any federally approved HIV test)
CL Item
Does The Participant Have The Ability And Willingness To Give Written Informed Consent (Does the participant have the ability and willingness to give written informed consent)
CL Item
Indicate Lymphoma Type: Diffuse Large B-cell/immunoblastic Lymphoma, Burkitt's Lymphoma, Or Hodgkin's Lymphoma (Indicate lymphoma type: Diffuse large B-cell/immunoblastic lymphoma, Burkitt's lymphoma, or Hodgkin's lymphoma)
CL Item
Is The Participant Willing To Undergo A Repeat Biopsy (Is the participant willing to undergo a repeat biopsy)
CL Item
Is The Participant, In The Opinion Of The Investigator, Capable Of Complying With This Protocol (Is the participant, in the opinion of the Investigator, capable of complying with this protocol)
CL Item
Participant's Age (in Years) (Participant's age (in years))